TrialOncoimmunology2024

LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcoma.

Morten Nielsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.